Medicament for inhibiting cancer cells without harmful effect to normal cells
The present invention relates to a pharmaceutical composition and a method for treating cancer, especially relates to a pharmaceutical composition including curative dose plant extract and pharmaceutically acceptable carrier and a method for treating cancer by using same.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
27.01.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to a pharmaceutical composition and a method for treating cancer, especially relates to a pharmaceutical composition including curative dose plant extract and pharmaceutically acceptable carrier and a method for treating cancer by using same. |
---|---|
AbstractList | The present invention relates to a pharmaceutical composition and a method for treating cancer, especially relates to a pharmaceutical composition including curative dose plant extract and pharmaceutically acceptable carrier and a method for treating cancer by using same. |
Author | CHENG LEI CHEN LEZONG ZHAO WENCHAO LIN XIAOLI LI MING ZHANG JIETING CHEN HAO |
Author_xml | – fullname: CHEN LEZONG – fullname: CHEN HAO – fullname: ZHANG JIETING – fullname: ZHAO WENCHAO – fullname: LIN XIAOLI – fullname: LI MING – fullname: CHENG LEI |
BookMark | eNqNyjsOwjAMANAMMPC7gzkAEiUCZlSBWMrEXpngEEuJUyWuuD4DHIDpLW9uJpKFZqbr6MkOE4mCzwVYAj9YWV7gUBwVcBRjhTdryKNCwJL8GIG8J6egGSSXhPHblmbqMVZa_VyY9eV8b68bGnJPdUBHQtq3t2bbHOzuaPcn-8_5ABBUN_s |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | CN101632735A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CN101632735A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 16:00:09 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CN101632735A3 |
Notes | Application Number: CN200910005243 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100127&DB=EPODOC&CC=CN&NR=101632735A |
ParticipantIDs | epo_espacenet_CN101632735A |
PublicationCentury | 2000 |
PublicationDate | 20100127 |
PublicationDateYYYYMMDD | 2010-01-27 |
PublicationDate_xml | – month: 01 year: 2010 text: 20100127 day: 27 |
PublicationDecade | 2010 |
PublicationYear | 2010 |
RelatedCompanies | THE CHINESE UNIVERSITY OF HONG KONG |
RelatedCompanies_xml | – name: THE CHINESE UNIVERSITY OF HONG KONG |
Score | 2.8261487 |
Snippet | The present invention relates to a pharmaceutical composition and a method for treating cancer, especially relates to a pharmaceutical composition including... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | Medicament for inhibiting cancer cells without harmful effect to normal cells |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100127&DB=EPODOC&locale=&CC=CN&NR=101632735A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6LzgwjSt6Jt0q-HIi5tGUK7IVP2NpquYR2jHVuH4F9v0nbOF30LSTiSC5fL3f3uAvBgmtwxLc7URIstYaA4XGV27KhPU2NqxCnmTipzh8PI7L-T17ExbsF8mwtT1Qn9rIojColKhLyX1X293DmxvApbuX5kmegqnoOR6ymNdaxVkVTF67n-cOANqEKpSyMlenOlkYqFqjZe9mBfN7Ap4V_-R09mpSx_q5TgBA6GglpenkLra9aBI7r9ea0Dh2ET8BbNRvbWZxDWMRXpzUPipYmyfJaxTKKWUSKPboWkE36NpGe12JRI1qTmmwWqERuoLFAu36eLeto53Af-iPZVsa7JDxMmNNptAV9AOy_y9BIQtkiMHaZNCXeIlTBbj3WuE5PbNicEsyvo_k2n-9_gNRzXkXJN1a0baJerTXorFHDJ7irOfQPSXItz |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3JTsJA9AXRiDdFjeI2JtqTjXRvD42RFgJCCzFovJFO2wlNSEtoidEP8judaYt4UeNtMvv25u1vAK5UlRiqRjDvC55GGRSD8Fj3DL4ZKIHihRIxQuY77Lhq90l-eFFeKvCx8oXJ44S-5sERKUT5FN6z_L2er4VYdm5bmd7iiGYld52xaXMldyzkmlTObpnt0dAeWpxlmZbLuY8mY1IliqqV-9Lpox--0bGC1OzZ9C5ci2KnPba6PKV6J18jTyx33U6idTZgk8Jjk5mOtZ9bzKNl_h0ddXZha0RnEmd7UHmf1qFmrX5tq8O2UyrLabKE23QfnEIfwySBiFKpKIqnEY6YxTPy2bEvEBPgp4hJZZNlhlg8a7KcocLaA2UJihltOyuqHcDln8s4hGqcxOERIEmTPcnAQiATQ9Z8rIueSERZJbpOZFnCx9D4uZ_Gb4UXUOuOncFk0HP7J7BTaNwFXtROoZotluEZReQZPs93EcHNf47gE-uyrco |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Medicament+for+inhibiting+cancer+cells+without+harmful+effect+to+normal+cells&rft.inventor=CHEN+LEZONG&rft.inventor=CHEN+HAO&rft.inventor=ZHANG+JIETING&rft.inventor=ZHAO+WENCHAO&rft.inventor=LIN+XIAOLI&rft.inventor=LI+MING&rft.inventor=CHENG+LEI&rft.date=2010-01-27&rft.externalDBID=A&rft.externalDocID=CN101632735A |